Your browser doesn't support javascript.
loading
Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia.
Wimmer, Megan R; Griffin, Meggie; Peterson-Weber, Alex; Schulz, Lucas T; Hamel, Ashlee G; Schwei, Rebecca J; Fong, Karen; Burgess, Donna R; Brett, Meghan; Hale, Cory M; Holubar, Marisa; Jain, Rupali; Larry, Rachel; Spivak, Emily S; Newland, Helen; Njoku, Jessica; Postelnick, Michael; Walraven, Carla; Pulia, Michael S.
Afiliação
  • Wimmer MR; Department of Pharmacy, University of Wisconsin Health, Madison, Wisconsin.
  • Griffin M; Department of Emergency Medicine, University of Wisconsin-Madison, Madison, Wisconsin.
  • Peterson-Weber A; Department of Pharmacy, University of Wisconsin Health, Madison, Wisconsin.
  • Schulz LT; Department of Pharmacy, University of Wisconsin Health, Madison, Wisconsin.
  • Hamel AG; Department of Pharmacy, Sentara Health, Norfolk, Virginia.
  • Schwei RJ; Department of Emergency Medicine, University of Wisconsin-Madison, Madison, Wisconsin.
  • Fong K; Department of Pharmacy, University of Utah Health, Salt Lake City, Utah.
  • Burgess DR; University of Kentucky Healthcare, Lexington, Kentucky.
  • Brett M; University of New Mexico Hospital, Albuquerque, New Mexico.
  • Hale CM; Department of Pharmacy, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Holubar M; Stanford University School of Medicine, Stanford California.
  • Jain R; University of Washington, Seattle, Washington.
  • Larry R; Department of Pharmacy, Infirmary Health, Mobile, Alabama.
  • Spivak ES; University of Utah Health, Salt Lake City, Utah.
  • Newland H; Barnes-Jewish Healthcare, St Louis, Missouri.
  • Njoku J; Harris Health System, Houston, Texas.
  • Postelnick M; Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois.
  • Walraven C; University of New Mexico Hospital, Albuquerque, New Mexico.
  • Pulia MS; Department of Emergency Medicine, University of Wisconsin-Madison, Madison, Wisconsin.
Infect Control Hosp Epidemiol ; 45(5): 667-669, 2024 May.
Article em En | MEDLINE | ID: mdl-38151334
ABSTRACT
We evaluated diagnostic test and antibiotic utilization among 252 patients from 11 US hospitals who were evaluated for coronavirus disease 2019 (COVID-19) pneumonia during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant pandemic wave. In our cohort, antibiotic use remained high (62%) among SARS-CoV-2-positive patients and even higher among those who underwent procalcitonin testing (68%).
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / COVID-19 Limite: Humans Idioma: En Revista: Infect Control Hosp Epidemiol Assunto da revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / COVID-19 Limite: Humans Idioma: En Revista: Infect Control Hosp Epidemiol Assunto da revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Ano de publicação: 2024 Tipo de documento: Article